// April 17, 2023
USP’s Preferential Access for Regulators (PAR) Program: Supporting the Global Supply of Quality Medicines
In the U.S. and around the world, quality standards developed by the U.S.
In the U.S. and around the world, quality standards developed by the U.S.
Quality should be built into the entire drug product lifecycle – including the manufacturing and
The quality of medicine and how it’s delivered to patients is fundamental to treating illness and
UPDATED: May 15, 2019